Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes

  • RnM3423194
    • |
  • 15 May, 2019
    • |
  • 75 Pages
    • |
  • GlobalData
    • |
  • Pharma & Healthcare

Check Discount on this report



Purchase this Report

$6,995.00
$13,990.00
$20,985.00
5,596.00
11,192.00
16,788.00
6,750.18
13,500.35
20,250.52
1,105,070.10
2,210,140.20
3,315,210.30
600,380.85
1,200,761.70
1,801,142.55
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo